These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11694862)

  • 1. Indication of vitamin E on microalbuminuria in patients with incipient diabetic nephropathy.
    Yokoyama M; Torita M; Yoshizawa M; Usuda R
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):611-2. PubMed ID: 11694862
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of taurine and vitamin E on microalbuminuria, plasma metalloproteinase-9, and serum type IV collagen concentrations in patients with diabetic nephropathy.
    Nakamura T; Ushiyama C; Suzuki S; Shimada N; Ohmuro H; Ebihara I; Koide H
    Nephron; 1999; 83(4):361-2. PubMed ID: 10575300
    [No Abstract]   [Full Text] [Related]  

  • 3. [Decrease of microalbuminuria caused by antihypertensive treatment in 10 diabetics with incipient diabetic nephropathy].
    Grimaldi A; Bosquet F; Coutarel P; Digy JP; Bordas M; Carayon A
    Ann Med Interne (Paris); 1987; 138(7):556-7. PubMed ID: 3439678
    [No Abstract]   [Full Text] [Related]  

  • 4. Early screening for nephropathy initiative.
    Monsaert RP
    Del Med J; 2006 Apr; 78(4):153-4. PubMed ID: 16719144
    [No Abstract]   [Full Text] [Related]  

  • 5. [Microalbuminuria in incipient diabetic nephropathy].
    Mosora N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(6):549-54. PubMed ID: 2882586
    [No Abstract]   [Full Text] [Related]  

  • 6. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetes mellitus and microalbuminuria].
    Krusová D
    Vnitr Lek; 2007 Dec; 53(12):1310-8. PubMed ID: 18357867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paricalcitol for reduction of albuminuria in diabetes.
    Delanaye P; Mariat C; Krzesinski JM; Cavalier E
    Lancet; 2011 Feb; 377(9766):635, author reply 636-7. PubMed ID: 21334526
    [No Abstract]   [Full Text] [Related]  

  • 9. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of vitamin E therapy on progression of diabetic nephropathy].
    Hirnerová E; Krahulec B; Strbová L; Stecová A; Dekrét J; Hájovská A
    Vnitr Lek; 2003 Jul; 49(7):529-34. PubMed ID: 12931434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microalbuminuria in diabetes: setting the points for treatment].
    Lehnert H; Klose S; Lobmann R; Zehnder D
    MMW Fortschr Med; 2006 May; 148(21):28-30, 33; quiz 34. PubMed ID: 16796185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria as a target to improve cardiovascular and renal outcomes.
    Basi S; Lewis JB
    Am J Kidney Dis; 2006 Jun; 47(6):927-46. PubMed ID: 16731288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria.
    Poulsen PL
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):17-26. PubMed ID: 12692749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paricalcitol for reduction of albuminuria in diabetes.
    Kassimatis T
    Lancet; 2011 Feb; 377(9766):635, author reply 636-7. PubMed ID: 21334524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.